[[{"fid":"1108","view_mode":"default","fields":{"format":"default","field_file_image_alt_text[und][0][value]":false,"field_file_image_title_text[und][0][value]":false},"type":"media","field_deltas":{"2":{"format":"default","field_file_image_alt_text[und][0][value]":false,"field_file_image_title_text[und][0][value]":false}},"link_text":null,"attributes":{"height":494,"width":730,"class":"media-element file-default","data-delta":"2"}}]]

Our Board in June 2017

(L - R): Jeffrey R. Williams, Lincoln C. Chen, Jane E. Henney, Anthony J. Saich, Suzanne E. Siskel, Wendy Harrison O'Neill, Barbara J. Stoll, Jeffrey P. Koplan.
(Not in picture: Fred Z. Hu, Harvey V. Fineberg, William Y. Yun)

Find below more information about our board members:

Mary Brown Bullock

Mary Brown Bullock, just completing her presidency of Agnes Scott College, is a China historian now serving as Visiting Distinguished Professor of China Studies at Emory University. In addition to chairing the board of trustees of the China Medical Board, she serves on the boards of the National Committee on US-China Relations, the National Science Foundation's Advisory Council on US-China Cooperation in Science, Policy, Research, and Education and the Asia Foundation. From 1988-1995, Dr. Bullock presided as director of the Asia Program at the Woodrow Wilson Center and from 1977-1988, she was director of the Committee on Scholarly Communication with the People's Republic of China. Dr. Bullock authored An American Transplant: The Rockefeller Foundation and Peking Union Medical College, which examines the history of the founding of the China Medical Board.

Lincoln C. Chen

Lincoln Chen is President of the China Medical Board of New York. His biography is in the staff page.

Harvey V. Fineberg

Harvey V. Fineberg is President of the Institute of Medicine. He served as Provost of Harvard University from 1997 to 2001, following thirteen years as Dean of the Harvard School of Public Health. He has devoted most of his academic career to the fields of health policy and medical decision making. His past research has focused on the process of policy development and implementation, assessment of medical technology, evaluation and use of vaccines, and dissemination of medical innovations. Dr. Fineberg helped found and served as president of the Society for Medical Decision Making and also served as consultant to the World Health Organization. At the Institute of Medicine, he has chaired and served on a number of panels dealing with health policy issues, ranging from AIDS to new medical technology. He also served as a member of the Public Health Council of Massachusetts (1976-1979), as chairman of the Health Care Technology Study Section of the National Center for Health Services Research (1982-1985), and as president of the Association of Schools of Public Health (1995-1996). Dr. Fineberg earned his bachelor's and doctoral degrees from Harvard University.

Jane E. Henney

Jane E. Henney, MD, is Professor of Medicineat the University of Cincinnati Academic Health Center. For nearly 30 years, Dr. Henney has served in a series of senior health policy leadership positions in the public sector. Beginning in 1980 she served for five years as the deputy director of the National Cancer Institute. Subsequently, she joined the University of Kansas Medical Center as vice chancellor of health programs, and for 18 months, interim dean of the School of Medicine. She then served as deputy commission for operations of the Food and Drug Administration, where she stayed until assuming the position as the first vice president for health sciences at the University of New Mexico.

In 1998, she was nominated by President Bill Clinton and confirmed by the U.S. Senate as the Commissioner of Food and Drugs, U.S. Food and Drug Administration. She served in this capacity until January 2001. After leaving the FDA, she was appointed senior scholar in residence at the Association of American Health Centers.

From July 2003 until the beginning of 2008, Dr. Henney served as Senior Vice President and Provost for Health Affairs at the University of Cincinnati.

In addition to her current academic responsibilities, she serves on the boards of the China Medical Board, the Commonwealth Fund, and Manchester Collge. She is a member of the Board of Directors of CIGNA and AmerisourceBergen Corporation. In addition she serves on a wide range of foundations, associations, and governmental advisory committees.

Dr. Henney has received many honors and awards in her field, including election to the National Academies of Science Institute of Medicine, the Society of Medical Administrators and honorary membership in the American College of Health Care Executives. She has received honorary degrees from North Carolina State University, Manchester College, University of Rochester, and Southern Illinois University Edwardsville.

Fred Z. Hu

Fred Z. Hu is a former partner and managing director at Goldman Sachs, were he served successively as chief economist, head of corporate strategy, co-head of investment banking, and chairman, Greater China. He currently is an advisory director to Goldman Sachs. Dr. Hu is a policy advisor to the Chinese government on financial and pension reform, restructuring of state-owned enterprises, and macroeconomic policies. He sits on the Hong Kong Government’s Strategic Development Committee and the Advisory Committee for the Hong Kong Securities and Futures Commission and is the co-chair of the Nature Conservatory’s China Board. He is co-director at the National Center for Economic Research, a professor at Tsinghua University, a member of the editorial board for several academic journals, and a columnist for China’s leading business magazines. Dr. Hu holds a master’s degree in engineering science from Tsinghua University and a master’s and PhD in economics from Harvard University.

Thomas S. Inui

Thomas S. Inui is President and CEO of the Regenstrief Institute for Health Care, the Sam Regenstrief Professor of Health Services Research, and Associate Dean for Health Care Research at Indiana University School of Medicine. A primary care physician, educator, and researcher, he previously held positions as head of general internal medicine at the University of Washington School of Medicine and as the Paul C. Cabot professor and founding chair of the Department of Ambulatory Care and Prevention at Harvard Medical School. Dr. Inui's special emphases in teaching and research have included physician/patient communication, health promotion and disease prevention, the social context of medicine, and medical humanities. His honors include elected membership in Phi Beta Kappa, Alpha Omega Alpha, the Johns Hopkins University Society of Scholars, the Institute of Medicine, a USPHS Medal of Commendation, serving as a member of the Council and President of the Society of General Internal Medicine, receipt of SGIM's Robert Glaser Award (for generalism), and election to the Institute of Medicine (and subsequently the IOM Council).

Thomas G. Kessinger

Thomas G. Kessinger is General Manager of the Aga Khan Foundation, responsible for overseeing the Foundation's work world-wide. In addition, he is Deputy Chairman of the Board of Aga Khan Development Network (AKDN). During 1988-1996 he served as the eleventh President of Haverford College. In 1977-1988, he worked with the Ford Foundation serving as regional representative in Jakarta and New Delhi. In 1961, he volunteered for Peace Corps work in rural India. In 1965 he entered the PhD program in history and anthropology at the University of Chicago focused on South Asia. His doctoral research, conducted in India, Pakistan and the United Kingdom, was the reconstruction of the social and economic history of an Indian village employing the research methods of history, anthropology, and cultural studies.

Jeffrey P. Koplan

Dr. Jeffrey P. Koplan is Director of the Emory Global Health Institute and Vice President for Global Health at Emory University. He is also a Co-founder and President of the International Association of National Public Health Institutes (IANPHI). A former director (1998-2002) and 26-year veteran of the U.S. Centers for Disease Control and Prevention (CDC), Dr. Koplan began his public health career in the early 1970s as a member of the CDC's Epidemic Intelligence Service. He has worked on many major public health issues, such as as the Bhopal chemical disaster, and the health toll of tobacco and chronic diseases around the globe. He has extensive international experience including assignments in Bangladesh, India, and Trinidad and Tobago. He has collaborated with Chinese health officials since his first visit to China in 1979. His work has included U.S.-China bilateral projects, World Bank missions, and World Health Organization consultations. He is an honorary professor and senior advisor to the China CDC. He is a Master of the American College of Physicians and a member of the U.S. Institute of Medicine. He has written more than 210 scientific papers. He is a trustee of The Robert Wood Johnson Foundation and the China Medical Board. He chairs the Visiting Committee to the School of Public Health of Harvard University and is on the Board of Advisors, the Health Policy Institute, Beijing University and serves on the Independent Monitoring Board, Global Polio Eradication Initiative.

Wendy Harrison O'Neill

WendyO’Neill is Chair Designate of the Asian Cultural Council where she has been a trustee since 2009. She has served as a trustee of the Rockefeller Brothers Fund since 2005 and sits on the Executive Committee. She is also a trustee of the Rockefeller Philanthropic Advisors since 2010 and serves on its Executive Committee. She was a member of the American Women's Association of Hong Kong's Charitable Donations Committee between 2001-2009 serving as its chairman for three years.

She received an A.B. from Harvard and Radcliffe Colleges in East Asian Studies and an M.A. from UCLA in history with a specialty in Chinese history. She has worked in China trade as well as investment in China and was the first foreign intern at China International Trust & Investment Company.

AnthonyJ. Saich

AnthonyJ. Saich is the director of the Ash Center for Democratic Governance and Innovation and Daewoo Professor of International Affairs at Harvard Kennedy School.Saich also serves as the director of the Rajawali Foundation Institutefor Asia and the faculty chair of the China Public Policy Program, which provides training programs for national and local Chinese officials.

Saich is a trustee member of International Bridges to Justice and sits on the executive committee of the John King Fairbank Center for Chinese Studies and the Asia Center, both at Harvard University. Saichalso isthe Harvard representative of the Kennedy Memorial Trust and previously was the representative for the Ford Foundation's China Office from 1994 to 1999. Prior to this, he was director of the Sinological Institute at Leiden University in the Netherlands. His current research focuses on politics and governance in post-Mao China; China's urbanization and rural-urban inequality in China; and the interplay between state and society in Asia. He holds a Ph.D. from the Faculty of Letters, University of Leiden, the Netherlands. He received his master's degree in politics with special reference to China from the School of Oriental and African Studies, London University, and his bachelor's degree in politics and geography from the University of Newcastle, UK.

Jeffrey R. Williams

Jeffrey R. Williams is the inaugural executive director ofthe Harvard Center Shanghai, which coordinates the university’s student programs, faculty research, case writing, conferences, and executive education programs offered in partnership with Chinese institutions. He has spent most of his career in East Asia, most recently as a private consultant in China. Prior to this, he was president of the Shenzhen Development Bank and the first foreigner to lead a Chinese bank since the founding of the People’s Republic of China. He worked in Taiwan and Hong Kong for Citibank and as the Taiwan general manager for American Express Co. and Standard Chartered Bank. Fluent in Mandarin, Mr. Williams was one of the first Americans to teach at Peking University after the resumption of diplomatic relations between China and the United States. He holds an A.B. in East Asian Languages and Literature from Harvard College and an M.B.A. from the Harvard Business School.

William Y. Yun

William Y. Yun has been Executive Vice President of Alternative Strategies at Franklin Resources, Inc. since 2008, and is responsible for Franklin Templeton's specialized and alternative investment groups. Mr. Yun is an officer of Franklin Resources, Inc. and a member of Franklin Templeton's Investment, Planning and Global Product Development Committees. He also serves on the Board of Directors of Fiduciary Trust Company International and is a member of Fiduciary Trust's Management Committee. He joined Fiduciary Trust in 1992 and was a portfolio manager for eight years, becoming executive vice president overseeing Fiduciary Trust's global equity division. He served as president of Fiduciary Trust from 2000 to 2005. In 2002, he also became president of Franklin Templeton Institutional, the global business development group responsible for Franklin Templeton's institutional business. Prior to joining Fiduciary Trust, Mr. Yun worked at Blyth Eastman Paine Webber, First Boston and CB Commercial Holdings. Mr. Yun is a Chartered Financial Analyst (CFA) Charterholder and a member of the New York Society of Security Analysts. He earned an M.B.A. from The Amos Tuck School of Business Administration at Dartmouth College, and a B.A. from Harvard University. Mr. Yun is also a trustee of the South Street Seaport Museum and The Commonwealth Fund in New York.